Cormorant Asset Management Overview

  • Investor Type
  • PE/​Buyout

  • Status
  • Active

  • Professionals
  • 4

Professionals

  • Investments
  • 268

  • Portfolio
  • 83

  • Exits
  • 149

Exits

Cormorant Asset Management General Information

Company Description

Founded in 2013, Cormorant Asset Management is a private equity firm based in Boston, Massachusetts. The firm seeks to invest in the life sciences, pharmaceuticals & biotechnology sectors.

Business Details

Website
www.cormorant.com
Year Founded
2013
Investor Status
Actively Seeking New Investments
Primary Investor Type
PE/Buyout
Other Investor Types
Hedge Fund
Corporate Office
  • 200 Clarendon Street
  • 52nd Floor
  • Boston, MA 02116
  • United States
+1 (857)

Cormorant Asset Management Investments (268)

Cormorant Asset Management’s most recent investment was a with Numab for . The deal was made on 09-Jan-2025 with as the lead partner.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Numab 09-Jan-2025 Drug Discovery Clinical Trials - Phase 1
Kala Bio 30-Dec-2024 Biotechnology Generating Revenue/Not Profitable
nChroma Bio 05-Dec-2024 Biotechnology Generating Revenue
Bright Minds 04-Nov-2024 Biotechnology Generating Revenue
Axonis Therapeutics 30-Oct-2024 Later Stage VC Drug Discovery Clinical Trials - Phase 1
You’re viewing 5 of 268 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cormorant Asset Management Exits (149)

Cormorant Asset Management has made a total of 149 exits. Its latest exit was from Chroma Medicine for on 11-Dec-2024. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size
Chroma Medicine 11-Dec-2024
Spyre Therapeutics 19-Nov-2024
OnKure Therapeutics 04-Oct-2024
BioAge Labs 26-Sep-2024
Artiva 19-Jul-2024 IPO
You’re viewing 5 of 149 exits. Get the full list »

Cormorant Asset Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Cormorant Asset Management FAQs

  • What is Cormorant Asset Management?

    Founded in 2013, Cormorant Asset Management is a private equity firm based in Boston, Massachusetts.

  • When was Cormorant Asset Management founded?

    Cormorant Asset Management was founded in 2013.

  • Where is Cormorant Asset Management headquartered?

    Cormorant Asset Management is headquartered in Boston, MA.

  • What is Cormorant Asset Management's total asset value?

    Cormorant Asset Management has around in total assets under management.

  • How many investments has Cormorant Asset Management made?

    Cormorant Asset Management has made 268 investments.

  • What has Cormorant Asset Management invested in?

    Cormorant Asset Management has made numerous investments in companies like Numab, Kala Bio, and nChroma Bio within the Drug Discovery and Biotechnology industries.

  • What has Cormorant Asset Management invested in recently?

    Cormorant Asset Management's latest investment was on 09-Jan-2025 in Numab, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »